Chinook Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Chinook Therapeutics, Inc.‘s stocks are currently a part of 92 hedge funds’ portfolios, which represents 33.33% of the total amount of its stocks outstanding. This makes up a total of 21.45M shares of Chinook Therapeutics, Inc.. Compared to the previous quarter, the number fell by -63.11% or -36.69M shares fewer. As for the holding position changes, 40.22% (37) of current hedge fund investors increased the number of shares held, 29.35% (27) of current holders sold a part of the shares held, and 5.43% (5) closed the holdings completely. 14 hedge funds are new holders of Chinook Therapeutics, Inc. stock in Q1 2023, it is 15.22% of total holders.
Hedge funds holding Chinook Therapeutics (Q1 2019 – Q1 2023)
| Q1 2019 | 1 |
|---|---|
| Q2 2019 | 1 |
| Q3 2019 | 1 |
| Q4 2019 | 1 |
| Q1 2020 | 1 |
| Q2 2020 | 1 |
| Q3 2020 | 6 |
| Q4 2020 | 75 |
| Q1 2021 | 75 |
| Q2 2021 | 87 |
| Q3 2021 | 83 |
| Q4 2021 | 101 |
| Q1 2022 | 103 |
| Q2 2022 | 131 |
| Q3 2022 | 147 |
| Q4 2022 | 150 |
| Q1 2023 | 92 |
Hedge funds changes in Chinook Therapeutics positions (Q1 2019 – Q1 2023)
| Q1 2019 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2019 | 0 | 0 | 0 | 0 | 1 |
| Q3 2019 | 0 | 0 | 0 | 0 | 1 |
| Q4 2019 | 0 | 0 | 0 | 0 | 1 |
| Q1 2020 | 0 | 0 | 0 | 0 | 1 |
| Q2 2020 | 0 | 0 | 0 | 0 | 1 |
| Q3 2020 | 5 | 0 | 0 | 0 | 1 |
| Q4 2020 | 70 | 2 | 2 | 1 | 0 |
| Q1 2021 | 8 | 15 | 26 | 8 | 18 |
| Q2 2021 | 24 | 36 | 14 | 11 | 2 |
| Q3 2021 | 8 | 40 | 20 | 11 | 4 |
| Q4 2021 | 24 | 50 | 17 | 7 | 3 |
| Q1 2022 | 14 | 38 | 32 | 12 | 7 |
| Q2 2022 | 41 | 55 | 24 | 12 | -1 |
| Q3 2022 | 30 | 68 | 28 | 14 | 7 |
| Q4 2022 | 20 | 58 | 46 | 17 | 9 |
| Q1 2023 | 14 | 37 | 27 | 5 | 9 |
Hedge funds changes in Chinook Therapeutics stock options (Q1 2019 – Q1 2023)
| Q1 2019 | 0 | 0 |
|---|---|---|
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 493,000 | 1,093,000 |
| Q1 2021 | 0 | 1,002,000 |
| Q2 2021 | 4,000 | 893,000 |
| Q3 2021 | 170,000 | 16,000 |
| Q4 2021 | 47,000 | 46,000 |
| Q1 2022 | 1,020,000 | 204,000 |
| Q2 2022 | 13,884,000 | 59,000 |
| Q3 2022 | 10,164,000 | 307,000 |
| Q4 2022 | 969,340 | 316,300 |
| Q1 2023 | 213,148,000 | 408,336,000 |